Introduction {#sec1-1}
============

Osteoarthritis (OA) is the second most common rheumatologic problem in India and has a prevalence rate of 22-39%.\[[@ref1]\] It is characterized primarily by articular cartilage degeneration and a secondary periarticular bone response.\[[@ref2][@ref3]\] World-wide prevalence rate of OA is 20% for men, 41% for women and it causes pain or dysfunction in 20% of the elderly respectively.\[[@ref4]\] Relieving pain stiffness and improving physical functions are the important goals of the present day therapy.\[[@ref5][@ref6]\] Although OA itself is not a life-threatening disease, Quality of life can significantly deteriorate with pain and loss of mobility causing dependence and disability.\[[@ref7]\] In Ayurveda, the disease *Sandhigata Vata* resembles with OA, which is described under *Vatavyadhi*.\[[@ref8]\]

*Anuvasana Basti* is the treatment of choice in *Vatavyadhi*.\[[@ref9]\] *Ksheerabala Taila* is one of the most popular oil preparations in Ayurveda and recognized as a very effective remedy for neurological disorders such as facial paralysis, sciatica, hemiplegia, paraplegia, poliomyelitis and other such conditions. The similar preparation has been mentioned by almost all ancient Ayurvedic texts but with different names. Charaka mentioned as *Shatasahasra Paka Bala Taila*.\[[@ref10]\] *Sushruta* mentioned as *Shata Paka Bala Taila*\[[@ref11]\] and Ashtanga Hridaya mentioned as *Shata Paka-Sahasra Paka Bala Taila*.\[[@ref12]\] The ingredients of this preparation are *Ksheera* (Cow\'s milk), *Bala* (*Sida cordifolia* Linn.) and *Tila Taila* (Sesame oil). *Ksheerabala Taila* is used for the purpose of *Anuvasana Basti*. *S. cordifolia* has been reported to possess analgesic, anti-inflammatory as well as hepato-protective activity.\[[@ref13][@ref14][@ref15]\] Charaka advises *Anuvasana Basti* to be administered in *Vatavyadhis*.\[[@ref16]\] The objective of the present study is to evaluate the effect of *Ksheerabala-Taila Anuvasana Basti* in *Sandhigata Vata*.

Materials and Methods {#sec1-2}
=====================

A total of 30 subjects with OA knees were recruited for the study among which 25 subjects (16 female and 9 male) completed the whole course and 5 dropped out. The study was approved by the Institutional Review Board (IRB) and Institutional Ethics Committee (IEC) (Ref No.: SDMAMC/03-04/D-1059). Signed informed consent was obtained from all the participants.

Inclusion criteria {#sec2-1}
------------------

Persistent pain for 3 months prior to recruitmentModerate-to-severe pain on walkingFully ambulant, literate and willing to participate in the study.

Exclusion criteria {#sec2-2}
------------------

Acute knee painSecondary OA due to rheumatoid arthritis, gout, septic arthritis, tuberculosis, tumor, trauma, or hemophiliaMajor medical or psychiatric disorders.

Design {#sec2-3}
------

It is a single group clinical study with pre-test and post-test design. A special proforma was prepared with all points of history taking, examination, laboratory and roentgen-logic investigations to confirm the diagnosis as mentioned in our classics and allied sciences.

Intervention {#sec2-4}
------------

The patients were treated with *Anuavasana Basti* with *Ksheerabala Taila* 120 ml for 10 days. 5 g of *Saindhava* was added to *Ksheerabala Taila* while administering *Basti*. The *Basti* was given daily between 2 pm and 3 pm in the afternoon after food.

The subjects were not given any other medications or topical treatments during the trial. The patients were assessed pre-test, post-test and after the follow-up period of 20 days.

*Basti Pratyagamana Laxanas* were all noted and No adverse events were noted during the trial.

Criteria for assessment {#sec2-5}
-----------------------

### Subjective parameters {#sec3-1}

I Visual Analog Scale (VAS) was used for assessing pain.

II Swelling

Grade 0 - No swellingGrade 1 - Slight swellingGrade 2 - Moderate swellingGrade 3 - Severe swelling

III Tenderness was evaluated on the basis of standard criteria of "Ritchie Articular Index."

Grade 0 - Normal - Absent or no tenderGrade 1 - Mild - TenderGrade 2 - Moderate - Tenderness and wincingGrade 3 - Severe - Tenderness, wincing and withdrawal

IV Crepitus

Grade 0 - Normal - No crepitusGrade 1 - Mild -- Crepitus complained by patient but not felt on examinationGrade 2 - Moderate - Crepitus felt on examinationGrade 3 - Severe - Crepitus felt and heard on examination

V Walking velocity

Grade 0 - Normal - 20 min in 20 sGrade 1 - Mild - 20 min in 30 sGrade 2 - Moderate - 20 min in 40 sGrade 3 - Severe - 20 min in 50 s

### Objective parameters {#sec3-2}

Radiological findings

The Kellgren-Lawrence index was used to assess the changes in radiological finding.

Grade 1 - Doubtful narrowing of joint space and possible osteophytic lippingGrade 2 - Definite osteophytes, definite narrowing of joint spaceGrade 3 - Moderate multiple osteophytes, definite narrowing of joints space, some sclerosis and possible deformity of bone contourGrade 4 - Large osteophytes, marked narrowing of joint space, severe sclerosis and definite deformity of bone contour

### Overall effect of therapy {#sec3-3}

No improvement: 0-25%, mild improvement: \>25-50%, moderate improvement: \>50-75%, marked improvement: \>75-\<100% and complete remission: 100%.

Observations {#sec1-3}
============

In present study, 48% of the patients gave a history of pain in both knee joints, while 40% complained of pain in right knee joint, only 12% in left knee joint. 84% of the patients were found were having *Santarpanottha* and 16% were *Apatarpanottha Vyadhi*. Majority of the patients (64%) had the history of complaints between 1 and 5 years, followed by more than 5 years (20%) and less than 1 year (16%). Maximum (52%) patients had Kellegren Roentgenologic evidence of OA in Grade 2, followed by Grade 3 (40%) and Grade 1 (8%). There were no patients in Grade 4.

Most of the patients had *Basti Pratyagama Kala* in 6-9 hrs (40%), followed by 3-6 hrs (32%), less than 3 hrs (16%) and more than 9 h (12%). The maximum *Basti* retension time noted was 9.53 h and minimum was 1.43 h. The mean *Basti* retention time was 4.56 h.

Results {#sec1-4}
=======

There was significant reduction (*P* \< 0.05) in subjective symptoms such as pain, swelling, tenderness, crepitus and walking velocity. There was insignificant change in radiological findings \[[Table 1](#T1){ref-type="table"}\]. In the overall effect of the therapy, 56% (14) had mild improvement, 48% (08) had moderate improvement and 12% (03) had no improvement.
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Discussion {#sec1-5}
==========

*Sandhigata Vata* is a disorder dominated by pain affecting the *Sandhi* (joint). It is caused by morbid *Vata Dosha*. *Kapha Dosha* may also be involved in the clinical presentation. The vitiated *Dosha* or *Doshas* afflict the *Mamsa*, *Asthi* and *Snayu*. It is more evident in *Asthi Dhatu* with which *Vayu* has *Ashraya-Ashrayee Bhava Sambhanda*.

As per age-wise distribution, maximum numbers of patients (60%) in this study were in the age group of 51-60 years. This is the age wherein *Hani* (deterioration) of *Dhatus* starts.\[[@ref17]\] In this study, maximum numbers of patients (64%) were females. Sex hormones have long been considered a possible factor in the systemic predisposition to OA, especially in women.\[[@ref18][@ref19][@ref20]\]

Nearly 16% of patients had chronicity below 1 year, whereas 64% of patients were between 1 and 5 years and remaining 20% of patients were more than 5 years.

Significant results (*P* \< 0.05) were found in all the cardinal symptoms -- *Sandhiruja* (pain), *Shotha* (swelling), tenderness and crepitus. There was significant improvement in walking velocity. This proves that *Anuvasana Basti* with *Ksheerabala Taila* is effective in *Sandhigata Vata*. Pain and crepitus are mainly due to *Vata Dosha* and above data proves that *Anuvasana Basti* with *Ksheerabala Taila* controls *Vata Dosha* and relieves these symptoms.

Probable mode of action of *Basti* {#sec2-6}
----------------------------------

*Basti Chikitsa* is the prime treatment modality of Ayurveda. It is also considered as *Ardha Chikitsa* (half treatment). *Sneha* or *Anuvasana Basti* (unctuous enema) promotes *Bala* (strength) of the person who is emaciated and debilitated. About the possibility of the absorption of *Basti Dravyas* (drugs) from the colon, some are of the opinion that substances other than water, salt, etc., are not absorbed from the large gut; but this is physiological phenomenon occurring in day-to-day life, while the colon mucosa under the effect of the medication can be rendered to absorb the unusual substance also from the large gut. Favoring this view modern medical science is suggestive of some of the nutrient enemas meant for the nutrition of the body, where absorption of carbohydrate, fat and protein is mentioned.\[[@ref21]\]

Observation of modern medical science that administration of sodium chloride improves fat absorption\[[@ref21]\] is curiously coinciding with the usage of salt designed by Ayurvedic medical authorities in *Sadyo-Snehana*\[[@ref22]\] and in many *Basti Dravya* preparations along with the different *Sneha Dravyas*. Charaka narrates the role played by *Lavana* along with the *Sneha* by the words "*Lavanopitaha Snehana Snehayantyachiratnaram*."\[[@ref23]\] Charaka while assessing the *Anuvasana Basti* records the digestion of *Sneha* by the words "*Sneham Pachati Pavakah*"\[[@ref24]\] and after digestion *Dravyas* can be absorbed to cause the affect on the body.

Conclusion {#sec1-6}
==========

*Anuvasana Basti* with *Ksheerabala Taila* was significant in reducing the subjective symptoms of *Sandhigata Vata*. There was no significant improvement in radiological findings.
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